Federal Register MedWatch Pharma News Warning Letters
Relpax (eletriptan) Tablets, 20 mg, 40 mg, and 80 mg, Pfizer NDA 21-016 Relpax (ELETRIPTAN), Pfizer Inc.
For the most up-to-date approval information, please locate this API using the drug index.